Results 41 to 50 of about 42,703 (190)

Development of a computer program for the diagnosis of polycystic ovary syndrome in women of early reproductive age

open access: yesФундаментальная и клиническая медицина, 2020
Aim. To develop the software for the diagnosis of polycystic ovary syndrome in women of early reproductive age.Material and Methods. We consecutively recruited 200 women of early reproductive age (18-35 years) with or without polycystic ovary syndrome ...
A. Yu. Beglova, S. I. Yelgina
doaj   +1 more source

Differences in clinical and endocrine features between obese and non-obese women in polycystic ovarian syndrome

open access: yesAdvanced Medical Journal, 2023
Background and objectives: The polycystic ovary syndrome is one of the commonest endocrine disturbance affecting 5-8% of reproductive age women. It is a heterogenous disorder that mainly presents with features of hyperandro- genism and anovulation ...
Awat Ibrahim Hamadamen   +3 more
doaj   +1 more source

A validated model of serum Anti-Müllerian hormone from conception to menopause [PDF]

open access: yes, 2011
<p><b>Background:</b> Anti-Mullerian hormone (AMH) is a product of growing ovarian follicles. The concentration of AMH in blood may also reflect the non-growing follicle (NGF) population, i.e.
Kelsey, Tom   +22 more
core   +1 more source

OVARIAN HYPERSTIMULATION SYNDROME ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME

open access: yes, 2023
<p>One of the highly serious side effects of assisted reproductive technologies is ovarian hyperstimulation syndrome. Ovarian hyperstimulation syndrome is at risk due to polycystic ovarian syndrome.
AKSİN, Şerif, YILMAZ, Mehmet
core   +1 more source

FREQUENCY OF POLYCYSTIC OVARIAN SYNDROME IN FEMALE MEDICAL STUDENTS OF COMBINED MILITARY HOSPITAL LAHORE MEDICAL COLLEGE

open access: yesPakistan Armed Forces Medical Journal, 2020
Objective: To determine the frequency of polycystic ovarian syndrome in female medical students and the risk factors associated with polycystic ovarian syndrome. Study Design: A cross-sectional analytical study.
Maria Ahmad   +4 more
doaj  

Polycystic Ovarian Syndrome

open access: yes, 2017
Polycystic ovarian syndrome (PCOS) was first described by Stein and Leventhal [1] in 1935. They reported the pathognomonic appearance of the ovaries seen during laparotomy in seven patients with hirsutism and amenorrhea (Fig. 2.1). The histological findings after surgical resection wedge were prominent teak, fibrotic thickening of the albuginea tunic ...
Ana Luisa Alencar De Nicola   +1 more
  +4 more sources

The anti-epileptic drug Valproic Acid (VPA) inhibits steroidogenesis in bovine theca and granulosa cells in vitro

open access: yes, 2012
Valproic acid (VPA) is used widely to treat epilepsy and bipolar disorder. Women undergoing VPA treatment reportedly have an increased incidence of polycystic ovarian syndrome (PCOS)-like symptoms including hyperandrogenism and oligo- or amenorrhoea.
Knight, PG   +19 more
core   +1 more source

Profile on personality types and cortisol in polycystic ovarian syndrome

open access: yesMiddle East Fertility Society Journal, 2018
Objective: To understand the profile of personality types and cortisol in patients with polycystic ovarian syndrome (PCOS). Methods: Cross-sectional study conducted in Infertility Polyclinic of Dr.
R. Muharam   +3 more
doaj   +1 more source

An adolescent girl with coexisting ovarian mature cystic teratoma and HAIR-AN syndrome, an extreme subtype of polycystic ovarian syndrome

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2021
Polycystic ovarian syndrome (PCOS) is associated with menstrual irregularities, ovulatory dysfunction, hirsutism, insulin resistance, obesity and metabolic syndrome but is rarely associated with severe hyperandrogenaemia and virilisation resulting in ...
Jin Hui Ho   +3 more
doaj   +1 more source

Application of Herbal Medicines for Obesity Treatment in the Polycystic Ovarian Syndrome Women

open access: yes, 2020
Polycystic ovarian syndrome (PCOS) is a frequent disorder commonly found in reproductive-aged women. The disease PCOS in women is considered to be complex heterogeneity, which indicates the combined combination of genetics and environmental interaction
Sameera A. Alghamdi
core   +1 more source

Home - About - Disclaimer - Privacy